The Quality of Life During Intravesical Bacillus Calmette-Guerin Therapy
Authors:
- 1 April 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 155 (4) , 1221-1226
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladderEuropean Journal of Cancer, 1993
- Psychosocial Adjustment and General State of Health In Patients With Ileal Conduit Urinary DiversionScandinavian Journal of Urology and Nephrology, 1992
- Assessing the Quality of Life of Cancer PatientsJournal of Psychosocial Oncology, 1989
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI: Journal of the National Cancer Institute, 1989
- Forschungsinstrumente zur Erfassung der Lebensqualität bei Krebs — ein Überblick1989
- The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy.Journal of Clinical Oncology, 1988
- Quality of Life after Cystectomy Comparison between Patients with Conduit and those with Continent Caecal Reservoir Urinary DiversionBritish Journal of Urology, 1988
- A Modular Approach to Quality-of-Life Assessment in Cancer Clinical Trials1988
- Local Immune Responses after Intravesical BCG Treatment for Carcinoma in situBritish Journal of Urology, 1987
- Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder CancerJournal of Urology, 1986